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Introduction
Ever since the initial reports that antigen-specific cyto-
lytic T lymphocytes (CTLs) are generated during allograft
rejection or viral infection [1], many attempts have been
made to elucidate the precise mechanism(s) by which
CTLs destroy target cells. Earlier in vitro studies demon-
strated that target-cell lysis requires intimate contact
between the CTL and its target and is highly specific, i.e.,
it does not affect antigenically irrelevant bystander target
cells. The assessment of target-cell lysis in vitro was facili-
tated by the development of assays based on the extra-
cellular release of radioactive markers from the cytoplasm
(e.g., 51Cr) or the nucleus (e.g., 125I-UdR) of labeled target
cells. Moreover, it was clearly established that CTL-medi-
ated lysis, in contrast to lysis induced by antibody and
complement, is not simply caused by a loss of the integ-
rity of the target cell plasma membrane (resulting in
colloid-osmotic lysis), but involves an active process sim-
ilar, if not identical, to apoptosis that includes nuclear
events such as chromatin condensation and extensive
DNA fragmentation.
Recent work indicates that two major mechanisms are
responsible, at least in vitro, for CTL-mediated lysis [2-5]:
(1) the exocytosis of cytolytic granules at the site of mem-
brane contact between the CTL and its target, resulting
in the local delivery of soluble lytic proteins such as
perforin and granzymes, and (2) the expression on the
CTL surface membrane of a molecule, the Fas ligand
(FasL), which induces a death signal upon engagement
with its receptor, Fas, on the target cell membrane.
The existence of two independent lytic pathways has
been clearly established in vitro by using CTL generated
in mice lacking perforin or with a nonfunctional Fas
ligand as well as target cells derived from Fas-deficient
mice. Moreover, such mice have been used to assess the
relative role of the two pathways in T-cell-mediated effec-
tor mechanisms in vivo. Here, we summarize the recent
advances made in the understanding of the molecular
mechanisms operating in CTL-mediated lysis in vitro. The
relevance of these findings to T-cell immunity is briefly
discussed.
The perforin/granzyme-dependent pathway
CD8+ CTLs possess specialized lytic granules which,
although they share distinctive features with regulated
secretory granules (such as those found in neuroendo-
crine cells, for example), are unusual in their nature, i.e.,
they are 'secretory lysosomes'. Indeed, while in most se-
cretory cells lysosomal and secretory granule components
are packaged into separate organelles, the CTL lytic
granules are organelles combining both secretory and
lysosomal compartments. In addition to classical lyso-
somal proteins, the granules contain several other pro-
teins, including perforin and a set of serine proteases
termed granzymes. Following recognition of the target
cell antigen (a complex made of an antigenic peptide
bound to a major histocompatibility complex class I
molecule) by the CTL antigen receptor (TCR), the gran-
ules within the CTL reorient toward the CTL target-cell
contact site and then fuse with the plasma membrane
resulting in the polarized delivery of their content.
It should be emphasized that CD8+ (naive) T cells do
not possess lytic granules before they are activated in a
primary response to antigen. Once they are activated into
CTLs, the presence of lytic granules with stored proteins
precludes the need for protein synthesis in perforin-
dependent CTL-mediated lysis. It appears, however, that
CTLs not only secrete lytic granules when they interact
with target cells, but may also be triggered to synthesize
additional lytic proteins that are stored in newly formed
granules or secreted directly from the cell via a constitu-
tive secretory pathway [4]. While this phenomenon may
explain the ability of a single CTL to kill in vitro several
target cells sequentially, its significance remains to be
defined in vivo.
Perforin, one of the soluble lytic proteins stored in
CTL granules, is a glycoprotein with sequence homology
to the complement component C9. It is generally agreed
that, following granule exocytosis, perforin monomers
can bind and insert into the target-cell plasma membrane
and subsequently aggregate to form homopolymeric pore
structures [3-6]. While pores visible by electron micro-
scopy contain 10-20 aggregated monomers, there is evi-
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dence that 3-4 monomers may already constitute a func-
tional channel. While such pores may perturb the perme-
ability of the target cell membrane, it is clear that this
effect is not sufficient to explain the various apoptotic
changes associated with CTL-mediated lysis. The search
for additional soluble mediators stored in CTL granules
has led to the identification of a family of serine protei-
nases termed granzymes [3, 7]. Granzyme B is by far the
most abundant granzyme in CTL granules and cleaves
proteins to the carboxyl site of acidic amino acids (e.g.,
aspartic acid). This substrate specificity is very unusual
among serine proteinases. Another granzyme, granzyme
A, exhibits a trypsinlike activity and thus cleaves proteins
to the carboxyl side of basic residues (e.g., arginine or
lysine). Following the demonstration that granzyme A or
B can induce DNA fragmentation in target cells permea-
bilized with a sublytic dose of perforin, it has been pro-
posed that granzymes are involved in target-cell apopto-
sis. As these soluble mediators have to enter the target
cell in order to activate the apoptotic program, perforin
may promote their entry, either directly through the poly-
perforin pores, or indirectly by stimulation of endocytosis.
The absolute requirement for perforin and granzyme
B in rapid CTL-mediated lysis has been confirmed un-
equivocally by studies using CTL generated in mice in
which the perforin gene or the granzyme B gene has been
destroyed by homologous recombination [7, 8]. Perforin-
or granzyme B-deficient mice develop normally and pro-
duce activated CD8+ cells upon appropriate antigenic
stimulation. However, activated perforin-deficient CD8+
cells are unable to lyse in vitro antigenically relevant
target cells (provided these target cells do not express
Fas; see below). Activated granzyme B-deficient CD8+
cells, although they induce 51Cr release from target cells,
are unable to induce rapid target cell DNA fragmenta-
tion. While these findings do not rule out that other CTL
granule proteins may play a supplementary role, they
point to the essential role of both perforin and granzyme
B in the triggering of target cell apoptosis resulting from
CTL granule exocytosis.
DNA damage induced by the perforin/granzyme-
dependent pathway does not depend on new protein syn-
thesis in the target cell. Thus, all the molecules necessary
for this pathway are already present, in contrast to some
other pathways leading to apoptosis. Although DNA
fragmentation is a biochemical hallmark of apoptosis, a
central role for DNA cleavage in the initiation of apop-
tosis has not been convincingly demonstrated. Indeed,
it appears that intracellular proteases, and not endonu-
cleases, are the primary initiators of apoptosis [9-11].
Accordingly, recent attention has focused on the identi-
fication of intracellular proteases that may serve as sub-
strate^) for granzyme B. While interleukin 1 (3 converting
enzyme (ICE) has been proposed as a putative substrate,
proteases related to ICE may be more relevant than ICE
itself. For example, a recently identified member of ICE-
related proteases involved in programmed cell death has
been shown to be activated by granzyme B. As this pro-
tease, termed apopain/Yama/CPP32, is also involved in
Fas-dependent apoptosis (see below), it may represent a
target cell component essential for CTL-mediated lysis.
The Fas ligand/Fas-dependent pathway
In addition to the regulated and polarized exocytosis of
lytic granules, another mechanism of CTL-mediated lysis
involves the interaction of membrane-bound Fas ligand
(FasL) on the CTL with its cognate receptor Fas on the
target-cell surface membrane, resulting in a signal leading
to apoptotic cell death [12-14].
FasL is a type II membrane protein belonging to the
tumor-necrosis-factor family. Interestingly, FasL is hardly
detectable on the surface of CTLs before they interact
with target cells. It is therefore likely that engagement of
the CTL TCR with its ligand on the target cell triggers
FasL expression at the CTL surface, in addition to exocy-
tosis of granules. In contrast to the latter phenomenon,
however, inhibition of RNA or protein synthesis in a
CTL prevents its ability to mediate target-cell lysis via
the FasL/Fas-dependent pathway, thus suggesting the
need for continuous FasL synthesis (or the production of
a putative FasL-activating protein).
Fas (CD95) is a type I membrane protein belonging to
the tumor-necrosis-factor-receptor family. Upon proper
engagement (including its cross-linking), Fas can trans-
duce an apoptotic signal. A 70-amino-acid-long segment
of the Fas cytoplasmic domain is necessary and sufficient
for transduction of the apoptotic signal and, hence, is
called a death domain. There is considerable variability in
the expression patterns of Fas in various tissues. Abun-
dant expression is found in liver, heart, kidney, and ovary.
Lymphocytes transformed with human T-cell leukemia
virus, human immunodeficiency virus, or Epstein-Barr
virus, as well as activated lymphocytes, express a rela-
tively large amount of Fas on the cell surface.
The biochemical mechanisms involved in the Fas-
dependent cytotoxic pathway are still poorly understood.
As mentioned earlier, there is increasing evidence that
activation of ICE-related cytoplasmic proteases such as
CPP32 and/or ICE-LAP3 [15] is an important step in the
mediation of apoptotic death. Recent studies suggest that
such an activation could be triggered by the association
of the Fas cytoplasmic domain with an intracellular
adaptor molecule termed FADD, leading to the assembly
of other proteins that participate in a cascade of enzy-
matic reactions resulting in the cleavage of several cyto-
plasmic and nuclear substrates. It is not yet clear whether
a single or several of the substrates of ICE-related pro-
teases may play a critical role in Fas-dependent cytotox-
icity.
The relative role of the FasL/Fas-dependent pathway
in CTL-mediated lysis has been clarified by the use of
CTL or target cells derived from mice with loss-of-func-
tion mutations in FasL or Fas, respectively [12]. In mice
carrying the gld (for generalized lymphoproliferative dis-
ease) mutation, there is a replacement of a phenylalanine
by a leucine in the extracellular C-terminus of FasL. This
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substitution abolishes the ability of FasL to bind to Fas.
In mice with the Ipr (for lymphoproliferative) mutation,
transcription of the Fas gene is impaired by the insertion
of a transportable element in an intron of the gene.
Another allelic mutation (lprcg) in the Ipr locus results in
the replacement of an isoleucine by an asparagine in the
Fas death domain, which affects the ability of Fas to
transduce the apoptotic signal.
With the availability of such mice, it is now feasible to
perform comparative in vitro assays in which normal
CTL, perforin-deficient CTL, and FasL-deficient CTL
are tested for lysis of Fas-positive or -negative target cells
[16]. Studies along this line indicate that there is little
cross-talk between the two mechanisms of CTL-mediated
lysis: perforin-deficient CTL can perfectly lyse Fas-pos-
itive target cells by means of the FasL/Fas-dependent
pathway, whereas FasL-deficient CTL and Fas-negative
target cells can lyse or be lysed, respectively, by means of
the perforin-dependent pathway. Moreover, while there is
direct evidence that the two pathways are operative in
CD8+ CTLs, it appears that CD4+ CTLs utilize primar-
ily, although not exclusively, the FasL/Fas-dependent
pathway, in contrast to NK cells, which utilize mainly
the perforin/granzyme-dependent pathway, although they
express FasL after activation [17,18].
Significance for T-cell immunity
It is generally assumed that T-cell-mediated cytotoxicity
is one of the major effector mechanisms responsible for
immunity to viruses, intracellular bacteria, and tumor
cells. With few exceptions, this assumption is mainly
based on circumstantial evidence, i.e., lack or loss of
specific immunity after depletion of CD8+ cells in vivo,
or indirect detection (i.e., after expansion in vitro) of
specific CTLs in immune mice. Since most CTLs also
secrete lymphokines, including interferon-y, upon target-
cell recognition, it is evident that effector mechanisms
other than cell-mediated cytotoxicity may be responsible
for CD 8+ cell-dependent immunity.
The availability of perforin-deficient mice now allows
the direct assessment of the role played by perforin-
dependent cytotoxicity in immune reactions in vivo [8].
The results reported so far indicate that the perforin-
dependent cytotoxic pathway plays a crucial role in the
immunological control of some viral infections, but not
of others (in spite of similar CTL responses). Similarly,
perforin-dependent cytotoxicity has been shown to play a
major role in immune protection against Listeria mono-
cytogenes, a model system for immunity against intra-
cellular bacteria. Impaired immune rejection of tumor
cells in perforin-deficient mice has been reported, but
further work is needed to ascertain the role of perforin-
dependent cytotoxicity in various model systems of tumor
immunity. An important role of perforin-dependent
cytotoxicity has also been established in model systems
of autoimmune tissue damage [19]. As far as rejection of
allogeneic grafts is concerned, the role of perforin-
dependent cytoxicity may be greatly influenced by the
tissue or organ involved as well as by the participation, or
lack thereof, of the graft vascular bed in the rejection
process.
In contrast to perforin-deficient mice, lymphocyte de-
velopment is abnormal in mice with Ipr ox gld mutations.
Indeed, these mice develop lymphadenopathy and sple-
nomegaly characterized by the accumulation of T lym-
phocytes which do not express the CD4 or CD8 surface
markers. It is likely that these lymphocytes correspond to
mature T cells which have not been eliminated after
antigen-induced activation because of the lack of a Fas-
based mechanism normally involved in the regulation of
T-cell homeostasis. Because of such abnormality, the use
of Ipr or gld mice to determine the role of FasL/Fas-
dependent cytotoxicity in T-cell immunity is relatively
limited. As shown recently, however, short term studies
based on the adoptive transfer of T cells from gld mice
may bring direct information as to the participation of
Fas-based immune mechanisms in vivo. In a model sys-
tem of lethal graft-versus-host disease (GVHD), spleen
cells from perforin-deficient mice or from FasL-deficient
mice were able to induce the disease, although mortality
was delayed compared to that observed after transfer of
normal T cells. In contrast, GVHD was abrogated when
spleen cells lacking both molecules were used as the
source of effector cells [20].
Conclusions
It is now clear that two independent pathways are in-
volved in T-cell-mediated cytotoxicity. The first one is
based on the local delivery of lytic proteins, including
perforin and granzymes, normally stored in CTL gran-
ules, whereas the second one depends on the expression
of both FasL on the CTL plasma membrane and Fas on
the target-cell membrane. Both pathways are triggered by
the engagement of the CTLTCR with its antigenic ligand
and result in target cell apoptosis. While the biochemical
mechanisms involved in the apoptotic processes mediated
by either pathway are still poorly understood, activation
of distinct target-cell cytoplasmic proteases belonging to
the ICE-like family may be a crucial step common to
both pathways. The relative role of the two pathways
in T-cell-mediated immunological phenomena in vivo
is under intensive investigation thanks to the availabil-
ity of mice deficient in one or the other molecule identi-
fied in vitro as a key component of T-cell-mediated
cytotoxicity. Elucidation of the mechanisms leading to
target-cell apoptosis in vivo will further our understand-
ing of the role of CTL in immunity and autoimmunity,
and may provide new tools for manipulating their ac-
tivity, positively or negatively, in a variety of immune
processes.
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